The Cardiac Marker Myoglobin (MYO) Rapid Test Cassette is a high-performance diagnostic tool designed for the qualitative detection of Myoglobin in human serum, plasma, or whole blood. By utilizing advanced immunochromatographic technology, this test provides critical early-stage indicators for myocardial infarction, enabling healthcare professionals to make rapid clinical decisions when every minute counts.
Engineered for maximum reliability and ease of use, the MYO Rapid Test requires no complex laboratory equipment or extensive technician training. Its high specificity ensures accurate results, while the seamless integration of a built-in procedural control guarantees the validity of every single test, making it an essential asset for emergency departments and point-of-care diagnostic settings.
Detailed Parameters
| Catalog Number | MYO-C30 | Product Type | Rapid Test Cassette |
|---|---|---|---|
| Specimen Type | Serum, Plasma, or Whole Blood | Cut-Off Value | 50 ng/mL |
| Test Size | 3.0mm | Result Time | 10-15 Minutes |
| Storage Temperature | 2-30°C | Packaging | Sealed foil pouch |
| Kit Components | 25 Test devices & droppers | Buffer Provided | Blood Lysis Buffer (10 mL) |
Key Advantages
High Specificity
Delivers accurate and reliable results with minimal cross-reactivity for precise cardiac marker detection.
Rapid Turnaround
Obtain clear, actionable diagnostic results in just 10 to 15 minutes to accelerate patient triage.
Internal Control
Features a built-in procedural control line to verify the test's integrity and result validity.
Zero Equipment
No additional reagents, expensive machinery, or specialized training required for operation.
Easy Interpretation
Simple visual readout allows for quick and intuitive interpretation of positive and negative results.
Stable Storage
Optimized for stability between 2-30°C, ensuring consistency across various clinical environments.
Product Gallery
Management Platforms
Inventory Control
Efficient tracking of batch numbers and expiration dates for medical consumable materials.
Quality Assurance
Strict adherence to medical device manufacturing standards for consistent test sensitivity.
Rapid Deployment
Optimized for emergency use cases and fast-paced medical diagnostic environments.
Compliance Ready
Designed to meet the rigorous documentation requirements of medical laboratories.
Kit Optimization
All-in-one packaging including lysis buffers and droppers for seamless operation.
Protocol Standard
Standardized Instructions for Use (IFU) included in every kit for error-free testing.
Investment Return Comparison
| Metric | Traditional Lab Test | MYO Rapid Test |
|---|---|---|
| Time to Result | Hours to Days | 10-15 Minutes |
| Equipment Cost | High Capital Investment | Zero (Equipment-free) |
| Labor Requirement | Specialized Pathologist | General Medical Staff |
| Patient Throughput | Limited by Machine Capacity | Unlimited Parallel Testing |
| Operational Cost | High per-sample cost | Low-cost disposable kits |
Frequently Asked Questions
Myoglobin is one of the earliest markers released into the blood following myocardial injury. Detecting elevated levels quickly helps in the early rule-out or rule-in of acute myocardial infarction (AMI).
Yes, the Cardiac Marker Myoglobin Rapid Test is compatible with serum, plasma, and whole blood, provided the included Blood Lysis buffer is used as per instructions.
Kits should be stored at temperatures between 2-30°C. It is critical that the test devices remain in their sealed foil pouches until the moment of use and must not be frozen.
The procedural control line confirms that the liquid has flowed through the membrane correctly and that the reagents were active, validating the test's performance.
No, the device is designed for ease of use. With the provided instruction manual, minimal training is required to perform the test and interpret the results accurately.
The cut-off value for this specific rapid test cassette is 50 ng/mL, providing a standardized benchmark for qualitative analysis.